Mehmet Altan
- Oncology top 1%
- Pulmonary and Respiratory Medicine top 2%
- Immunology top 5%
- Epidemiology top 10%
- Molecular Biology
- Co-authors
- David L. RimmKurt A. SchalperDaniel Carvajal‐HausdorfRoy S. HerbstYinghong WangMaria TokiHamzah Abu‐SbeihMark M. Awad
- Topics
- Cancer Immunotherapy and Biomarkers (74 papers)Lung Cancer Treatments and Mutations (41 papers)Lung Cancer Research Studies (17 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaGastroenterology
- Partner nations
- United StatesChinaGreece
In The Last Decade
Mehmet Altan
114 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 88
- Oncology 2.1k
- Pulmonary and Respiratory Medicine 885
- Immunology 559
- Epidemiology 376
- Molecular Biology 364
Countries citing papers authored by Mehmet Altan
This map shows the geographic impact of Mehmet Altan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehmet Altan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehmet Altan more than expected).
Fields of papers citing papers by Mehmet Altan
This network shows the impact of papers produced by Mehmet Altan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehmet Altan. The network helps show where Mehmet Altan may publish in the future.
Co-authorship network of co-authors of Mehmet Altan
This figure shows the co-authorship network connecting the top 25 collaborators of Mehmet Altan. A scholar is included among the top collaborators of Mehmet Altan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mehmet Altan. Mehmet Altan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 5 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 17 | |
| 10 | 6 | |
| 11 | 23 | |
| 12 | 8 | |
| 13 | 2 | |
| 14 | 19 | |
| 15 | 9 | |
| 16 | 40 | |
| 17 | 35 | |
| 18 | 108 | |
| 19 | 160 | |
| 20 | 28 |
About Mehmet Altan
Mehmet Altan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology, having authored 121 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (74 papers), Lung Cancer Treatments and Mutations (41 papers) and Lung Cancer Research Studies (17 papers). The work is most often cited by research in Oncology (2.1k citations), Pulmonary and Respiratory Medicine (885 citations) and Immunology (559 citations). Mehmet Altan has collaborated with scholars based in United States, China and Greece. Frequent co-authors include David L. Rimm, Kurt A. Schalper, Daniel Carvajal‐Hausdorf, Roy S. Herbst, Yinghong Wang, Maria Toki, Hamzah Abu‐Sbeih, Mark M. Awad, Scott Gettinger and Patricia Gaule. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.